Mostrar el registro sencillo del ítem
dc.contributor.author | Ruiz Sánchez, Jorge Gabriel | |
dc.contributor.author | Núñez Gil, Iván Javier | |
dc.contributor.author | Cuesta, Martín | |
dc.contributor.author | Rubio, Miguel Ángel | |
dc.contributor.author | Maroun Eid, Charbel | |
dc.contributor.author | Arroyo Espliguero, Ramón | |
dc.contributor.author | Romero Pareja, Rodolfo | |
dc.contributor.author | Becerra Muñoz, Víctor Manuel | |
dc.contributor.author | Uribarri, Aitor | |
dc.contributor.author | Runkle, Isabelle | |
dc.contributor.author | Et al. | |
dc.date.accessioned | 2022-05-13T07:04:51Z | |
dc.date.available | 2022-05-13T07:04:51Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Ruiz-Sánchez, J. G., Núñez-Gil, I. J., Cuesta, M., Rubio, M. A., Maroun-Eid, C., Arroyo-Espliguero, R., Romero, R., Becerra-Muñoz, V. M., Uribarri, A., Feltes, G., Trabattoni, D., Molina, M., García Aguado, M., Pepe, M., Cerrato, E., Alfonso, E., Castro Mejía, A. F., Roubin, S. R., Buzón, L., Bondia, E., … HOPE COVID-19 investigators (2020). Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis. Frontiers in endocrinology, 11, 599255. https://doi.org/10.3389/fendo.2020.599255 | spa |
dc.identifier.issn | 1664-2392 | |
dc.identifier.uri | http://hdl.handle.net/11268/11236 | |
dc.description.abstract | Dysnatremia is associated with increased mortality in patients with community-acquired pneumonia. SARS-COV2 (Severe-acute-respiratory syndrome caused by Coronavirus-type 2) pneumonia can be fatal. The aim of this study was to ascertain whether admittance dysnatremia is associated with mortality, sepsis, or intensive therapy (IT) in patients hospitalized with SARS-COV2 pneumonia. This is a retrospective study of the HOPE-COVID-19 registry, with data collected from January 1th through April 31th, 2020. We selected all hospitalized adult patients with RT-PCR-confirmed SARS-COV2 pneumonia and a registered admission serum sodium level (SNa). Patients were classified as hyponatremic (SNa <135 mmol/L), eunatremic (SNa 135-145 mmol/L), or hypernatremic (SNa >145 mmol/L). Multivariable analyses were performed to elucidate independent relationships of admission hyponatremia and hypernatremia, with mortality, sepsis, or IT during hospitalization. Four thousand six hundred sixty-four patients were analyzed, median age 66 (52-77), 58% males. Death occurred in 988 (21.2%) patients, sepsis was diagnosed in 551 (12%) and IT in 838 (18.4%). Hyponatremia was present in 957/4,664 (20.5%) patients, and hypernatremia in 174/4,664 (3.7%). Both hyponatremia and hypernatremia were associated with mortality and sepsis. Only hyponatremia was associated with IT. In conclusion, hyponatremia and hypernatremia at admission are factors independently associated with mortality and sepsis in patients hospitalized with SARS-COV2 pneumonia. | spa |
dc.description.sponsorship | Sin financiación | spa |
dc.language.iso | eng | spa |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.other | Infecciones por coronavirus | spa |
dc.subject.other | Hiponatremia | spa |
dc.subject.other | Hipernatremia | spa |
dc.title | Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis | spa |
dc.type | article | spa |
dc.description.impact | 5.555 JCR (2020) Q1, 32/146 Endocrinology & Metabolism | spa |
dc.description.impact | 1.518 SJR (2020) Q1, 28/232 Endocrinology, Diabetes and Metabolism | spa |
dc.description.impact | No data IDR 2020 | spa |
dc.identifier.doi | 10.3389/fendo.2020.599255 | |
dc.rights.accessRights | openAccess | spa |
dc.subject.unesco | Virus | spa |
dc.subject.unesco | Aparato respiratorio | spa |
dc.description.filiation | UEM | spa |
dc.peerreviewed | Si | spa |